Suppr超能文献

胰腺导管腺癌患者来源异种移植瘤中的肿瘤植入与不良临床病理特征及较差生存率相关。

Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.

作者信息

Pergolini Ilaria, Morales-Oyarvide Vicente, Mino-Kenudson Mari, Honselmann Kim C, Rosenbaum Matthew W, Nahar Sabikun, Kem Marina, Ferrone Cristina R, Lillemoe Keith D, Bardeesy Nabeel, Ryan David P, Thayer Sarah P, Warshaw Andrew L, Fernández-Del Castillo Carlos, Liss Andrew S

机构信息

Department of Surgery and the Andrew L. Warshaw, MD Institute for Pancreatic Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

Department of Surgery, Universita' Politecnica delle Marche, Ancona, Italy.

出版信息

PLoS One. 2017 Aug 30;12(8):e0182855. doi: 10.1371/journal.pone.0182855. eCollection 2017.

Abstract

Patient-derived xenograft (PDX) tumors are powerful tools to study cancer biology. However, the ability of PDX tumors to model the biological and histological diversity of pancreatic ductal adenocarcinoma (PDAC) is not well known. In this study, we subcutaneously implanted 133 primary and metastatic PDAC tumors into immunodeficient mice. Fifty-seven tumors were successfully engrafted and even after extensive passaging, the histology of poorly-, moderately-, and well-differentiated tumors was maintained in the PDX models. Moreover, the fibroblast and collagen contents in the stroma of patient tumors were recapitulated in the corresponding PDX models. Analysis of the clinicopathological features of patients revealed xenograft tumor engraftment was associated with lymphovascular invasion (P = 0.001) and worse recurrence-free (median, 7 vs. 16 months, log-rank P = 0.047) and overall survival (median, 13 vs. 21 months, log-rank P = 0.038). Among successful engraftments, median time of growth required for reimplantation into new mice was 151 days. Reflective of the inherent biological diversity between PDX tumors with rapid (<151 days) and slow growth, differences in their growth were maintained during extensive passaging. Rapid growth was additionally associated with lymph node metastasis (P = 0.022). The association of lymphovascular invasion and lymph node metastasis with PDX formation and rapid growth may reflect an underlying biological mechanism that allows these tumors to adapt and grow in a new environment. While the ability of PDX tumors to mimic the cellular and non-cellular features of the parental tumor stroma provides a valuable model to study the interaction of PDAC cells with the tumor microenvironment, the association of successful engraftment with adverse clinicopathological features suggests PDX models over represent more aggressive forms of this disease.

摘要

患者来源的异种移植(PDX)肿瘤是研究癌症生物学的有力工具。然而,PDX肿瘤模拟胰腺导管腺癌(PDAC)生物学和组织学多样性的能力尚不清楚。在本研究中,我们将133个原发性和转移性PDAC肿瘤皮下植入免疫缺陷小鼠体内。57个肿瘤成功移植,即使经过广泛传代,PDX模型中低分化、中分化和高分化肿瘤的组织学特征仍得以保留。此外,患者肿瘤基质中的成纤维细胞和胶原蛋白含量在相应的PDX模型中得到重现。对患者临床病理特征的分析显示,异种移植肿瘤的植入与淋巴管侵犯相关(P = 0.001),无复发生存期更差(中位数,7个月对16个月,对数秩检验P = 0.047),总生存期也更差(中位数,13个月对21个月,对数秩检验P = 0.038)。在成功植入的肿瘤中,再次植入新小鼠所需的中位生长时间为151天。反映出快速生长(<151天)和缓慢生长的PDX肿瘤之间固有的生物学差异,它们在广泛传代过程中生长差异依然存在。快速生长还与淋巴结转移相关(P = 0.022)。淋巴管侵犯和淋巴结转移与PDX形成及快速生长之间的关联可能反映了一种潜在的生物学机制,使这些肿瘤能够在新环境中适应和生长。虽然PDX肿瘤模拟亲代肿瘤基质细胞和非细胞特征的能力为研究PDAC细胞与肿瘤微环境的相互作用提供了有价值的模型,但成功植入与不良临床病理特征的关联表明,PDX模型过度代表了该疾病更具侵袭性的形式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a2/5576681/974511acdce7/pone.0182855.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验